| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.47▼ | 2.48▼ | 2.48▼ | 2.57▼ | 2.31▲ |
| MA10 | 2.53▼ | 2.52▼ | 2.52▼ | 2.36▲ | 2.85▼ |
| MA20 | 2.52▼ | 2.53▼ | 2.55▼ | 2.23▲ | 3.97▼ |
| MA50 | 2.54▼ | 2.42▲ | 2.30▲ | 2.93▼ | 3.02▼ |
| MA100 | 2.39▲ | 2.38▲ | 2.59▼ | 4.30▼ | 2.45▼ |
| MA200 | 2.53▼ | 3.15▼ | 3.15▼ | 3.39▼ | 2.79▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.018▼ | -0.024▼ | 0.101▲ | -0.315▼ |
| RSI | 45.742▼ | 47.939▼ | 49.595▼ | 48.158▼ | 43.002▼ |
| STOCH | 27.632 | 27.632 | 30.530 | 73.516 | 13.544▼ |
| WILL %R | -89.474▼ | -89.474▼ | -73.913 | -43.662 | -88.584▼ |
| CCI | -88.248 | -87.232 | -59.111 | 52.976 | -53.278 |
|
Tuesday, May 27, 2025 01:11 AM
Next-generation immunotherapy cancer drug company Indaptus Therapeutics Inc. (NASDAQ:INDP) narrowed its loss and hit key milestones during Q1 as it advanced its quest to exploit bacteria's natural ...
|
|
Tuesday, March 18, 2025 12:46 AM
On Tuesday, Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. The expansion will evaluate the combination of Decoy20 ...
|
|
Monday, March 17, 2025 05:00 PM
Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 2.5499 | 2.5499 | 2.36 | 2.44 | 13,613 |
| 11/12/25 | 2.57 | 2.57 | 2.45 | 2.57 | 11,000 |
| 10/12/25 | 2.68 | 2.68 | 2.50 | 2.65 | 26,668 |
| 09/12/25 | 2.75 | 2.936 | 2.391 | 2.60 | 165,300 |
| 08/12/25 | 2.52 | 2.70 | 2.45 | 2.61 | 39,900 |
| 05/12/25 | 2.1702 | 2.50 | 2.135 | 2.50 | 84,562 |
| 04/12/25 | 2.21 | 2.223 | 2.12 | 2.14 | 15,700 |
| 03/12/25 | 2.02 | 2.16 | 2.02 | 2.16 | 10,500 |
| 02/12/25 | 2.01 | 2.085 | 1.97 | 2.00 | 6,700 |
| 01/12/25 | 2.23 | 2.35 | 1.93 | 1.95 | 53,600 |
|
|
||||
|
|
||||
|
|